1Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.
2Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.
3Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
4Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
5Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.
6Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea.
7Department of Internal Medicine, Mitochondrial Research Group, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.
8Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
9Division of Health and Nutrition Survey, Korea Centers for Disease Control and Prevention, Cheongwon, Korea.
Copyright © 2013 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Values are presented as mean±standard deviation. Data were analyzed excluding 46 participants with missing variables. HbA1c, glycated hemoglobin; FPG, fasting plasma glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; HTN, hypertension; BMI, body mass index; WC, waist circumference; TC, total cholesterol; TG, triglyceride; eGFR, estimated glomerular filtration rate were calculated using the Cockcroft-Gault formula; Hb, hemoglobin; AST, aspartate aminotransferase; ALT, alanine aminotransferase. a
NFG refers to FPG <100 mg/dL and/or HbA1c <5.7%. IFG refers to FPG of 100 to 125 mg/dL and/or HbA1c of 5.7% to 6.4%. FPG, fasting plasma glucose; NFG, normal fasting glucose; IFG, impaired fasting glucose; DM, diabetes mellitus; HbA1c, glycated hemoglobin.
Values are presented as mean±standard deviation. FPG, fasting plasma glucose; HbA1c, glycated hemoglobin. aThe prevalence of diabetes is based on a 2011 population estimate.
Values are presented as mean±standard deviation. FPG, fasting plasma glucose; HbA1c, glycated hemoglobin. aThe prevalence of diabetes is based on a 2011 population estimate.